News
27 April 2021
BAP Pharma Limited sign an exclusive agreement for the supply and distribution of Bicillin® LA (Penicillin G Benzathine pre-filled syringe) to treat patients with bacterial infections in the UK and Europe.
BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)
Product Details
Bicillin® L-A is a ready-to-use Benzathine Benzylpenicillin, also known as Penicillin G Benzathine (PBG) slow-onset, long-acting antibiotic in prefilled syringes that fights bacteria in the body.
Bicillin® L-A belongs to the group of penicillin antibiotics and works by killing bacteria or preventing their growth. This particular type of Bicillin is called Bicillin® L-A because it is long-acting.
Bicillin® L-A is supplied as a prefilled syringe in a pack of ten, for single use only.
Product Usage
Bicillin® L-A is used to treat a wide variety of venereal bacterial infections in different parts of the body caused by bacteria, such as Syphilis, Yaws, Bejel and Pinta, as well as Rheumatic Fever and/or Chorea.
Product Approval
Bicillin® L-A (Penicillin G Benzathine) has received approval from the Food and Drug Administration (FDA)
For More Information
To obtain additional information regarding Bicillin® LA (Penicillin G Benzathine) Expanded Access Program, please contact our Medicines Access team at: [email protected] or call: 01753 980250.
BAP Pharma Limited
BAP Pharma are global leaders in clinical trial supply, specialising in Medicines Access, Comparator Sourcing and Secondary Packaging & Labelling.
We work with our clients to provide bespoke solutions to ensure patients can gain access to the treatment they require through commercial supply or on a named patient basis. Our extensive experience in the pharmaceutical industry and our global storage and distribution capabilities, allows us to fully understand customer supply needs and truly deliver on our promise.
‘Promise Delivered’
Our focus is on delivering a high-quality, well-informed service to customers, ensuring that we proactively manage the whole supply from start to finish, using quality partners. This ensures products are received in the perfect condition.
BAP Pharma’s added value assures clients that our dedicated team will provide innovative solutions. This allows compliant and uncomplicated access to their product and maximises the potential of their product at the Pre- and Post-Approval stage. This increases patient access to sought-after medicines that were previously unavailable.
The BAP Pharma group have headquarters in the UK, Germany & USA and partners with storage facilities across the world, which gives us a true global reach.
You Might Also Like
BAP Pharma Granted Clinical Secondary Packaging and Labelling Licence
BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Clinical Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator
Walk All Over Cancer Challenge 2021
At the beginning of March 2021, a group of volunteers came together from BAP Pharma Ltd, to form the BAP Steppers. Their aim – to take on the Walk All Over Cancer challenge for Cancer Research UK. The BAP Steppers put on their walking shoes and braved the unpredictable weather,
BAP Pharma awarded EcoVadis Silver Sustainability Rating
BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide. EcoVadis review more than 75,000 companies based on four main areas: Environment Labour & Human Rights Ethics